LSL Pharma Group Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	0.3	0.01	-	0.74	1.93
Cash & Short-Term Investments	0.3	0.01	-	0.74	1.93
Cash Growth	3600.00%	-	-	-61.52%	-
Accounts Receivable	4.95	2.55	0.97	1.12	2.22
Other Receivables	0.01	0.13	0.07	0.22	0.19
Receivables	4.96	2.68	1.04	1.33	2.4
Inventory	9.12	4.11	2.96	4.17	2.13
Prepaid Expenses	1.01	0.41	0.21	0.13	0.05
Other Current Assets	-	-	0.19	0.11	-
Total Current Assets	15.38	7.2	4.4	6.48	6.51
Property, Plant & Equipment	22.94	14.75	13.92	12.89	10.3
Goodwill	0.16	-	-	-	-
Other Intangible Assets	13.27	8.93	8.98	9.39	9.81
Long-Term Deferred Tax Assets	0.22	-	-	-	0.1
Other Long-Term Assets	1.54	0.02	0.02	0.28	0.46
Total Assets	53.51	30.9	27.31	29.03	27.18
Accounts Payable	5.2	4.92	4.54	2.54	2.47
Accrued Expenses	-	1.06	1.58	1.17	1.64
Short-Term Debt	2.56	3.77	2.91	-	-
Current Portion of Long-Term Debt	1.45	5.22	1.58	1.89	6.03
Current Portion of Leases	0.45	0.12	0.14	0.19	0.24
Current Unearned Revenue	-	-	0.01	-	0.51
Other Current Liabilities	-	-	0.87	1.46	1.66
Total Current Liabilities	9.65	15.07	11.62	7.25	12.55
Long-Term Debt	12.75	4.73	7.84	7.98	3.36
Long-Term Leases	4.43	2.44	2.56	2.69	0.94
Long-Term Deferred Tax Liabilities	1.79	-	-	-	-
Total Liabilities	28.62	22.25	22.02	17.92	16.84
Common Stock	36.39	24.2	15.05	12.81	10.26
Additional Paid-In Capital	3.05	2.32	-	-	-
Retained Earnings	-14.92	-18.23	-9.76	-1.7	0.08
Comprehensive Income & Other	0.38	0.38	-	-	-
Shareholders' Equity	24.89	8.66	5.29	11.11	10.34
Total Liabilities & Equity	53.51	30.9	27.31	29.03	27.18
Total Debt	21.64	16.27	15.03	12.74	10.57
Net Cash (Debt)	-21.34	-16.26	-15.03	-12	-8.64
Net Cash Per Share	-0.19	-0.20	-0.23	-0.20	-0.16
Filing Date Shares Outstanding	136.54	82.44	68.09	62.66	54.89
Total Common Shares Outstanding	136.54	82.44	68.09	62.66	54.89
Working Capital	5.72	-7.87	-7.22	-0.78	-6.04
Book Value Per Share	0.18	0.10	0.08	0.18	0.19
Tangible Book Value	11.46	-0.28	-3.69	1.72	0.54
Tangible Book Value Per Share	0.08	-0.00	-0.05	0.03	0.01
Land	-	0.28	0.28	0.28	0.28
Buildings	-	3.97	3.91	3.63	3.51
Machinery	-	6.02	5.55	5.33	4.73
Construction In Progress	-	-	1.77	0.47	-
Leasehold Improvements	-	3.71	0.93	0.93	0.82

Source: S&P Global Market Intelligence. Standard template. Financial Sources.